Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Final Trade: VRSK, BMY, VZ, APO, GM
06:19pm, Monday, 10'th Mar 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Bristol Myers Unveils Positive Phase 3 Results for Sotyktu in Psoriatic Arthritis
12:54pm, Monday, 10'th Mar 2025
On Saturday, Bristol Myers Squibb & Co BMY revealed data from the pivotal Phase 3 POETYK PsA-2 trial (IM011-055) evaluating the efficacy and safety of Sotyktu (deucravacitinib) in adults with activ
EC Approves Bristol Myers' Opdivo Plus Yervoy for First-Line HCC
10:45am, Monday, 10'th Mar 2025
The EC approves BMY's combination of Opdivo and Yervoy for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma.
Recession Could Be Coming: 5 Strong Buy High-Yield Dividend Stocks That Will Still Outperform
08:16am, Monday, 10'th Mar 2025
The last time the economy experienced two negative quarters of gross domestic product was the first and second quarters of 2022, with a 1.6% pullback in the first quarter and a 0.6% decline in the sec
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #AAD--Bristol Myers Squibb Presents Late-Breaking Data from Phase 3 POETYK PsA-2 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared.
I'm Locking 9-11% FCF Yields On These Dividend Icons
08:00am, Saturday, 08'th Mar 2025
Bristol Myers Squibb and Alexandria Real Estate offer strong free cash flow yields and appealing dividends, making them attractive in volatile markets. BMY's low valuation, robust drug pipeline, and c
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CheckMate--Bristol Myers Squibb Receives European Commission Approval for Opdivo plus Yervoy for the First-Line Treatment of Adult Patients with Unresectable
Bristol Myers Squibb (BMY) Ascends While Market Falls: Some Facts to Note
06:46pm, Thursday, 06'th Mar 2025
Bristol Myers Squibb (BMY) concluded the recent trading session at $60.18, signifying a +0.6% move from its prior day's close.
Final Trade: SBUX, GAP, SLV, BMY
06:35pm, Thursday, 06'th Mar 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Bristol-Myers Squibb Company (BMY) Presents at 45th Annual TD Cowen Health Care Conference (Transcript)
06:14pm, Tuesday, 04'th Mar 2025
Bristol-Myers Squibb Company (NYSE:BMY ) 45th Annual TD Cowen Health Care Conference March 4, 2025 2:30 PM ET Company Participants Adam Lenkowsky - Executive Vice President & Chief Commercial Officer
Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb
01:45am, Tuesday, 04'th Mar 2025
Ongoing strategic partnership advances joint pipeline in neurodegeneration research Evotec receives a $20 million payment to further progress research HAMBURG, DE / ACCESS Newswire / March 4, 2025 / E
Bristol Myers Squibb Announces Dividend
04:16pm, Monday, 03'rd Mar 2025
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend.
The Artificial Intelligence Party Over for Now? Safe 4%+ High-Yield Dividend Blue Chips Are On Sale
07:46am, Friday, 28'th Feb 2025
Dividend stocks are a favorite among investors for good reason. They provide a steady income stream of passive income and offer a promising avenue for total return.
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:05am, Wednesday, 26'th Feb 2025
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
04:32am, Wednesday, 26'th Feb 2025
Healthcare is considered a defensive industry, since good medical care is needed regardless of economic or market conditions. Therefore many companies in this sector are somewhat insulated from the im
